» Articles » PMID: 36558998

Autophagy-Related NcRNAs in Pancreatic Cancer

Overview
Publisher MDPI
Specialty Chemistry
Date 2022 Dec 23
PMID 36558998
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer (PC) is a malignancy accounting for only 3% of total cancers, but with a low 5-year relative survival rate. Approximately 80% of PC patients are diagnosed at a late stage when the disease has already spread from the primary site. Despite advances in PC treatment, there is an urgently needed for the identification of novel therapeutic strategies for PC, particularly for patients who cannot undergo classical surgery. Autophagy is an evolutionarily conserved process used by cells to adapt to metabolic stress via the degrading or recycling of damaged or unnecessary organelles and cellular components. This process is elevated in PC and, thus, it contributes to the onset, progression, and cancer cell resistance to chemotherapy in pancreatic tumors. Autophagy inhibition has been shown to lead to cancer regression and to increase the sensitivity of pancreatic cells to radiation and chemotherapy. Emerging studies have focused on the roles of non-coding RNAs (ncRNAs), such as miRNAs, long non-coding RNAs, and circular RNAs, in PC development and progression. Furthermore, ncRNAs have been reported as crucial regulators of many biological processes, including autophagy, suggesting that ncRNA-based autophagy targeting methods could be promising novel molecular approaches for specifically reducing autophagic flux, thus improving the management of PC patients. In this review, we briefly summarize the existing studies regarding the role and the regulatory mechanisms of autophagy-related ncRNAs in the context of this cancer.

Citing Articles

Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy.

Jalouli M Int J Mol Sci. 2025; 26(4).

PMID: 40004215 PMC: 11855875. DOI: 10.3390/ijms26041752.


The Multifaceted Role of miR-21 in Pancreatic Cancers.

Chen C, Demirkhanyan L, Gondi C Cells. 2024; 13(11.

PMID: 38891080 PMC: 11172074. DOI: 10.3390/cells13110948.


Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.

Wang K, Wang X, Pan Q, Zhao B Mol Cancer. 2023; 22(1):167.

PMID: 37803304 PMC: 10557192. DOI: 10.1186/s12943-023-01870-3.

References
1.
Li J, Chen X, Kang R, Zeh H, Klionsky D, Tang D . Regulation and function of autophagy in pancreatic cancer. Autophagy. 2020; 17(11):3275-3296. PMC: 8632104. DOI: 10.1080/15548627.2020.1847462. View

2.
Liu Y, Luo D, Li X, Li Z, Yu X, Zhu H . PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer. Pancreas. 2021; 50(2):227-234. DOI: 10.1097/MPA.0000000000001747. View

3.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

4.
Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L . MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology. 2013; 145(5):1133-1143.e12. DOI: 10.1053/j.gastro.2013.07.048. View

5.
Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View